zuclopenthixol (Q228143)

Zuclopenthixol (English)

3 October 2016

chemical formula

C₂₂H₂₅ClN₂OS

1 reference

Zuclopenthixol (English)

19 November 2016

canonical SMILES

C1CN(CCN1CCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO

1 reference

Zuclopenthixol (English)

19 November 2016

isomeric SMILES

C1CN(CCN1CC/C=C\2/C3=CC=CC=C3SC4=C2C=C(C=C4)Cl)CCO

1 reference

Zuclopenthixol (English)

https://www.whocc.no/atc_ddd_index/?code=N05AF05

19 November 2016

defined daily dose

30 milligram

route of administration

oral administration

1 reference

reference URL

15 milligram

route of administration

parenteral route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=N05AF05

30 milligram

route of administration

parenteral route of administration

1 reference

reference URL

https://www.whocc.no/atc_ddd_index/?code=N05AF05

World Health Organisation international non-proprietary name

zuclopenthixol (English)

1 reference

zuclopenthixol (English)

significant drug interaction

3 October 2016

ondansetron

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-methadone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amiodarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

arsenic trioxide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

disopyramide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toremifene

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sotalol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

anagrelide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

moxifloxacin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

erythromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clarithromycin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dronedarone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

vandetanib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

crizotinib

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Pasireotide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-hydroxyzine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-citalopram

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tetrabenazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apomorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

tolterodine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pentamidine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

mefloquine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

domperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

fingolimod

1 reference

A reference set of clinically relevant adverse drug-drug interactions

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ivabradine

torsades de pointes

1 reference

A reference set of clinically relevant adverse drug-drug interactions

sotalol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

cabergoline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

levomepromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(RS)-sulpiride

1 reference

A reference set of clinically relevant adverse drug-drug interactions

paliperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

risperidone

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(E/Z)-doxepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

droperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

pimozide

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

haloperidol

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

chlorpromazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clomipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

apomorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

toxic encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(±)-promethazine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

ivabradine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

trimipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

amitriptyline

1 reference

A reference set of clinically relevant adverse drug-drug interactions

(E/Z)-doxepin

1 reference

A reference set of clinically relevant adverse drug-drug interactions

aripiprazole

1 reference

A reference set of clinically relevant adverse drug-drug interactions

quetiapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

imipramine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

olanzapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

clozapine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

buprenorphine

1 reference

A reference set of clinically relevant adverse drug-drug interactions

extrapyramidal symptoms

1 reference

A reference set of clinically relevant adverse drug-drug interactions

encephalopathy

1 reference

A reference set of clinically relevant adverse drug-drug interactions

dyskinesia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

asthenia

1 reference

A reference set of clinically relevant adverse drug-drug interactions

brain injury

1 reference

A reference set of clinically relevant adverse drug-drug interactions

Commons category

Zuclopenthixol

0 references

Identifiers

InChI

InChI=1S/C22H25ClN2OS/c23-17-7-8-22-20(16-17)18(19-4-1-2-6-21(19)27-22)5-3-9-24-10-12-25(13-11-24)14-15-26/h1-2,4-8,16,26H,3,9-15H2/b18-5-

1 reference

Zuclopenthixol (English)

WFPIAZLQTJBIFN-DVZOWYKESA-N

19 November 2016

InChIKey

2 references

Zuclopenthixol (English)

19 November 2016

ChEBI release 2020-09-01

CAS Registry Number

53772-83-1

2 references

zuclopenthixol (English)

WFPIAZLQTJBIFN-DVZOWYKESA-N

19 November 2016

InChIKey

10 April 2021

https://commonchemistry.cas.org/detail?cas_rn=53772-83-1

1 reference

Zuclopenthixol (English)

19 November 2016

1 reference

Zuclopenthixol (English)

19 November 2016

Reaxys registry number

8447014

1 reference

zuclopenthixol (English)

3 October 2016

ChEBI ID

51364

mapping relation type

1 reference

CLOPENTHIXOL (English)

19 November 2016

1 reference

CLOPENTHIXOL (English)

19 November 2016

1 reference

MassBank accession ID

MSBNK-Waters-WA001868

0 references

MSBNK-Waters-WA001869

0 references

MSBNK-Waters-WA001870

0 references

MSBNK-Waters-WA001871

0 references

MSBNK-Waters-WA001872

0 references

DSSTox substance ID

DTXSID3048233

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

DTXCID4028208

0 references

EC number

258-758-5

1 reference

zuclopenthixol (English)

ECHA Substance Infocard ID

19 November 2016

100.053.398

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.053.398

27 December 2018

Zuclopenthixol (English)

quotation

CAS no.: 53772-83-1 (English)

1 reference

Guide to Pharmacology Ligand ID

Zuclopenthixol (English)

publication date

17 November 2015

7559

1 reference

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

7559

zuclopenthixol (English)

19 November 2016

0 references

1 reference

zuclopenthixol (English)

19 November 2016

1 reference

Zuclopenthixol (English)

Human Metabolome Database ID

19 November 2016

HMDB0015561

1 reference

based on heuristic

inferred from InChIKey

1 reference

zuclopenthixol (English)

19 November 2016

0 references

1 reference

1 reference